An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 162 - 168 of 912
Why protective antibodies fade after COVID-19 vaccines
New findings could help explain why the immune protection generated by COVID-19 vaccines tends to decline over time.
Sex differences in how the body reduces pain
A study suggests that meditation for pain relief may work through different systems in females and males.
Time-restricted eating for metabolic syndrome
People with metabolic syndrome who limited their eating to an 8 to 10 hour period each day had modest health benefits after three months.
Complete wiring map of an adult fruit fly brain
Researchers fully mapped the connections between neurons for an entire adult fruit fly brain.
Brain waste-clearance system shown in people for first time
A study in five volunteers undergoing surgery confirmed the existence of channels that may help drain waste from the brain.
Research in Context
Can we slow aging?
Researchers are making progress in understanding the biology of aging and learning ways it might be slowed down or even reversed.
Different exercise patterns bring health benefits
People who fit most of their exercise into one or two days a week had the same reduced risk of disease as people who spread their activity throughout the week.